US health reform makes progress, along with $4bn “sucker-punch” tax on medtech
This article was originally published in Clinica
The US medtech industry has given an understandably mixed response to the Senate finance committee’s approval on October 13 of a package of measures that will radically transform the American healthcare system. The sore point for industry is that a $4bn annual medtech tax remains in the reform proposal.
You may also be interested in...
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.